Andrés E Dulcey

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Smoking Cessation

Positron Emission Tomography

Small Cell Lung Cancer

Top Venues

The Journal of clinical endocrinology and metabolism

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Rhitajit Sarkar, Priyanka Bolel, Abhijeet Kapoor, Elena Eliseeva, Andrés E Dulcey, Jay S Templin, Amy Q Wang, Xin Xu, Noel Southall, Joanna Klubo-Gwiedzdzinska, Susanne Neumann, Juan Jose Marugan, Marvin Carl Gershengorn
An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers. The Journal of clinical endocrinology and metabolism 109 (9) (2024)
Rhitajit Sarkar, Priyanka Bolel, Abhijeet Kapoor, Elena Eliseeva, Andrés E Dulcey, Jay S Templin, Amy Q Wang, Xin Xu, Noel Southall, Joanna Klubo-Gwiedzdzinska, Susanne Neumann, Juan Jose Marugan, Marvin Carl Gershengorn
An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers. The Journal of clinical endocrinology and metabolism (2024)
Rhitajit Sarkar, Priyanka Bolel, Abhijeet Kapoor, Elena Eliseeva, Andrés E Dulcey, Jay S Templin, Amy Q Wang, Xin Xu, Noel Southall, Joanna Klubo-Gwiedzdzinska, Susanne Neumann, Juan Jose Marugan, Marvin Carl Gershengorn
An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers. The Journal of clinical endocrinology and metabolism 109 (9) (2024)
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, Trevor B Doyle, Ramona M Rodriguiz, Vladimir M Pogorelov, Mayako Machino, Kuo Hao Lee, Jeremiah W Bertz, Jinbin Xu, Herman D Lim, Andrés E Dulcey, Robert H Mach, James H Woods, J Robert Lane, Lei Shi, Juan Jose Marugan, William C Wetsel, David R Sibley
Identification and Characterization of ML321: A Novel and Highly Selective D 2 Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity. ACS pharmacology & translational science 6 (1) (2022)
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, Trevor B Doyle, Ramona M Rodriguiz, Vladimir M Pogorelov, Mayako Machino, Kuo Hao Lee, Jeremiah W Bertz, Jinbin Xu, Herman D Lim, Andrés E Dulcey, Robert H Mach, James H Woods, J Robert Lane, Lei Shi, Juan Jose Marugan, William C Wetsel, David R Sibley
Identification and Characterization of ML321: A Novel and Highly Selective D 2 Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity. ACS pharmacology & translational science 6 (1) (2022)